Anzu Special Acquisition Corp I reported its financial results for the second quarter of 2021, revealing a net income of $371,144 for the three months ended June 30, 2021, contrasting with a net loss of $1,099,292 for the six-month period. The company, which went public on March 4, 2021, generated gross proceeds of $425 million from its initial public offering (IPO) and an additional $12.5 million from the sale of private placement warrants. As of June 30, 2021, Anzu held total assets of approximately $427.8 million, a significant increase from $119,992 at the end of 2020, primarily due to the IPO proceeds.

The company’s balance sheet showed current assets of $2.8 million, including cash and cash equivalents of $1.7 million, and cash held in a trust account amounting to $425 million. Current liabilities totaled $670,637, with accounts payable and accrued expenses contributing to this figure. The substantial increase in assets and liabilities reflects the company's transition from a blank check company to one actively seeking a business combination, as it has not yet commenced operations.

Anzu's operational focus remains on identifying high-quality businesses with transformative technologies for industrial applications. The company has been actively reviewing potential acquisition targets but has not finalized any business combination as of the reporting date. The management indicated that they have sufficient funds to pursue these opportunities, with a deadline to complete a business combination by March 4, 2023. The company does not expect to generate operating revenues until after such a transaction is completed.

In terms of organizational changes, Anzu's capital structure has evolved, with 4,333,119 shares of Class A common stock and 10,625,000 shares of Class B common stock outstanding as of June 30, 2021. The company also reported a derivative warrant liability of $25.6 million, reflecting the fair value of warrants issued in connection with the IPO. The management noted a material weakness in internal controls related to the accounting for these warrants, which were reclassified as liabilities following guidance from the SEC.

Looking ahead, Anzu Special Acquisition Corp I aims to leverage its capital to identify and execute a business combination that aligns with its strategic focus. The company is committed to utilizing the funds in its trust account for this purpose while managing its operational expenses through cash held outside the trust account. The management remains optimistic about finding suitable acquisition targets that can drive growth and profitability in the future.

About Envoy Medical, Inc.

Envoy Medical, Inc. is a pioneering hearing health company dedicated to transforming the treatment of hearing loss through innovative medical technologies. Its flagship product, the Acclaim CI, is a fully implanted cochlear implant designed to enhance the quality of life for individuals with severe to profound hearing loss. Targeting a significant market opportunity of over $80 billion, Envoy is focused on improving patient access and outcomes while navigating regulatory pathways for FDA approval.

This description was generated via AI from the most recent annual report. Updated 4 months ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.